[
  {
    "ts": null,
    "headline": "Why Gilead Sciences (GILD) Dipped More Than Broader Market Today",
    "summary": "In the latest trading session, Gilead Sciences (GILD) closed at $123.18, marking a -1.38% move from the previous day.",
    "url": "https://finnhub.io/api/news?id=659b5cae5dbaf1cf69025363e95f982420ed6c42e181afacbf268633ee9827b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767135003,
      "headline": "Why Gilead Sciences (GILD) Dipped More Than Broader Market Today",
      "id": 137950424,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "In the latest trading session, Gilead Sciences (GILD) closed at $123.18, marking a -1.38% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=659b5cae5dbaf1cf69025363e95f982420ed6c42e181afacbf268633ee9827b4"
    }
  },
  {
    "ts": null,
    "headline": "Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 19, Gilead Sciences, Inc. (NASDAQ:GILD) announced an agreement with the US government aimed at lowering drug costs for Americans. The move reinforces the company’s long-standing focus on US-based innovation, affordability, and global health leadership. Under the […]",
    "url": "https://finnhub.io/api/news?id=f7328b6ba6f7f2e5e3ace1f5978f9cfbbd131ed6ebd481417673ee75344c9bf5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767134559,
      "headline": "Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs",
      "id": 137950425,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 19, Gilead Sciences, Inc. (NASDAQ:GILD) announced an agreement with the US government aimed at lowering drug costs for Americans. The move reinforces the company’s long-standing focus on US-based innovation, affordability, and global health leadership. Under the […]",
      "url": "https://finnhub.io/api/news?id=f7328b6ba6f7f2e5e3ace1f5978f9cfbbd131ed6ebd481417673ee75344c9bf5"
    }
  },
  {
    "ts": null,
    "headline": "New Edge Wealth's Jay Peters says 2026 will be the year of diversification",
    "summary": "Jay Peters, New Edge Wealth, joins 'Power Lunch' to talk the three stocks he is watching for 2026.",
    "url": "https://finnhub.io/api/news?id=41ab3acfec007888a5c1ff2b1990eaf45efafaff6fdeeefc9cf4ca892b25be67",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767105662,
      "headline": "New Edge Wealth's Jay Peters says 2026 will be the year of diversification",
      "id": 137950611,
      "image": "https://image.cnbcfm.com/api/v1/image/108246826-17671230551767123053-43247128381-1080pnbcnews.jpg?v=1767123055&w=1920&h=1080",
      "related": "GILD",
      "source": "CNBC",
      "summary": "Jay Peters, New Edge Wealth, joins 'Power Lunch' to talk the three stocks he is watching for 2026.",
      "url": "https://finnhub.io/api/news?id=41ab3acfec007888a5c1ff2b1990eaf45efafaff6fdeeefc9cf4ca892b25be67"
    }
  },
  {
    "ts": null,
    "headline": "Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ:GILD) announced on December 22 that it has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) helicase-primase inhibitor programs, which include long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. Management reported […]",
    "url": "https://finnhub.io/api/news?id=d15899368ababe34dfb426151579cf55ee69f682178a41ee5dfcdcc34692ae23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767070790,
      "headline": "Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?",
      "id": 137940427,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ:GILD) announced on December 22 that it has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) helicase-primase inhibitor programs, which include long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. Management reported […]",
      "url": "https://finnhub.io/api/news?id=d15899368ababe34dfb426151579cf55ee69f682178a41ee5dfcdcc34692ae23"
    }
  }
]